AstraZeneca Pharmaceuticals LP
Real-world evidence at ECCMID 2024 further substantiates the continued[...]
10/28/2021 | Press release | Distributed by Public on 10/28/2021 04:38
Please select the service you want to use:
Smartlinks | Nielsen Holdings plc | News | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Market Research | Arts and Culture | Entertainment | Media | Media and Publishing | Public Companies | Market Research and Polling Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Börse Berlin | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | Tradegate Exchange | NYSE American | NYSE ARCA Equities | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact